Descriptive profiling of these biomarkers, including CXCL9, angiopoietin-2, and soluble E-selectin, suggests their potential value in understanding endothelial dysfunction, macrophage activation, and immune dysregulation in MIS-C. This evidence concerns the gene CXCL9 and endothelial dysfunction.